Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine-Reference-Cited by-同舟云学术

Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine

Published:2018-07 Issue:4 Volume:16 Page:236-248
ISSN:2095-4964
Container-title:Journal of Integrative Medicine
language:en
Short-container-title:Journal of Integrative Medicine

Author:

Ling Chang-quan,Fan Jia,Lin Hong-sheng,Shen Feng,Xu Zhen-ye,Lin Li-zhu,Qin Shu-kui,Zhou Wei-ping,Zhai Xiao-feng,Li Bai,Zhou Qing-hui

Funder

National Natural Science Foundation of China

E-Institutes of Shanghai Municipal Education Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference105 articles.

1. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 (2014-10-9) [2018-01-19]. http://globocan.iarc.fr/Default.aspx.

2. Diagnosis and treatment guidelines for hepatocellular carcinoma (2017 edition);National Health and Family Planning Commission of the PRC;Zhonghua Xiao Hua Wai Ke Za Zhi,2017

3. Modern oncology;Tang,2011

4. Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existed problems;Wu;Zhong Xi Yi Jie He Xue Bao,2003

5. Combination of traditional Chinese medicine and Western medicine in the treatment of liver cancer;Tang;Lin Chuang Gan Dan Bing Za Zhi,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies;Phytomedicine;2024-10

2. Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition);Liver Research;2024-06

3. Transcription factor <i>ASCL1</i> targets <i>SLC6A13</i> to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling;Biomolecules and Biomedicine;2024-05-21

4. The perioperative experience and needs of hepatocellular carcinoma patients in interventional therapy: a phenomenological qualitative study;European Journal of Gastroenterology & Hepatology;2024-02-21

5. Magnesium metal and its corrosion products: Promising materials for tumor interventional therapy;Journal of Magnesium and Alloys;2023-03